Zacks Investment Research
29 Dec 2025, 15:41 UTC · 38w ago
Verdict
Headline takes no side. We score AORT +0.50 — strongly bullish.
+0.50strongly bullish
More positive than 63% of ticker scores this week
Which stocks this story touches
More positive than 63% of ticker scores this week
Artivion noted for outperforming its sector with a 62% year-to-date return, upward earnings estimate revisions, and a Zacks Rank #2 (Buy).
More positive than 63% of ticker scores this week
Idexx Laboratories highlighted with strong year-to-date performance (66.5%), positive earnings revisions, and a Zacks Rank #2 (Buy), indicating favorable analyst sentiment.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 19% of relationship scores this week
[mutual] Idexx Laboratories and Artivion are both identified as Medical sector stocks in the same Medical - Instruments industry, implying they compete for investor attention and potentially in overlapping market segments.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−49.6%
Price is moving against the score
$23.34 vs $46.31 close before publication (Dec 26) · not market-adjusted
AORT chart →